Why a type of ‘GLP-1’ weight loss fibre could soon be added to food to make you eat less - IN FOCUS: As a ‘supercharged’ ...

Could Ozempic curb violence? A new study suggests GLP-1 drugs may weaken the link between impulsivity and aggressive behavior ...

GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...

GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...

Experts describe the development of oral GLP-1 medication as a “pivotal” improvement in the accessibility and adherence to obesity drugs. As of February 2026, only Wegovy and Rybelsus are available in ...

The use of weight-loss injections has sky-rocketed, sometimes leading to unique or strange side effects. The most recent concern? Hair loss. Here’s a look at the facts. ByTanya Akim, Contributor.

GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting "GLP-3s," claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) ...

With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be related to weight loss alone. GLP-1 medications, including semaglutide, are a ...

Share on Pinterest A new study compares the risks and benefits of using GLP-1 medications. Iuliia Burmistrova/Getty Images The use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for ...

Many people hadn’t even heard of GLP-1 before a couple of years ago. And yet we’ve had it in our bodies all along. GLP-1 is a natural hormone made in the gut that’s released after we eat. It ...

Modern medicine is continually advancing treatment options for many chronic health conditions. For type 2 diabetes, obesity, and weight management, GLP-1 receptor agonists are medications that may ...

The medical device market is expected to grow to almost $800 billion by 2030. Here's a list of the year's best opportunities. The United States has a $115.5 billion trade deficit in pharmaceutical ...